George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
A therapy for type 1 diabetes is the first to treat patients before symptoms appear, paving the way toward preventing this and other autoimmune diseases.
Scientists present the latest research on the immune response against SARS-CoV-2, the influence of COVID-19 on future vaccine responses, and drivers of T cell development.
Check out Words for Nerds, the science-themed wordle game where you can challenge yourself and share with your colleagues to see who comes out on top. There is a new word every day! #wordsfornerds
Thanks for reading! Our inbox is always open, so if you have thoughts or ideas about this newsletter or tips for our news team, we'd love to hear from you.
Want More? We also offer curated newsletters that focus in on research areas, including Microbiology and Genetics & Genomics.
Advertisement
Follow The Scientist
Never miss an email from The Scientist. Click hereto add The Scientist to your safe-sender list.
The Scientist,1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll-Free: (888) 781-0328 | Phone: (705) 528-6888 Email: privacy@the-scientist.com